| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07759804 A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension… | Phase 4 | Not Yet Recruiting |
| 2026-08-05 | NCT07748000 A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07759804 | A Study of Inhaled Treprostinil (LIQ861) in Adults With Pulmonary Arterial Hypertension… | Pulmonary Arterial Hypertension (PAH) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07285655 | A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD | Pulmonary Hypertension Due to Lung Disease (Disorder) | Recruiting |
| NCT03992755 | Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry… | Primary Pulmonary Hypertension | Active, Not Recruiting |
| NCT04691154 | A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or… | Pulmonary Arterial Hypertension | Active, Not Recruiting |
| Phase 2 | |||
| NCT07748000 | A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have… | Raynaud's Phenomenon Secondary to Systemic Sclerosis | Not Yet Recruiting |
| Not specified | |||
| NCT06129240 | An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry… | Pulmonary Hypertension | Recruiting |